Antidiabetic drugs are medicines used to control blood glucose levels in patients with diabetes mellitus. These drugs work through different mechanisms, including increasing insulin secretion, improving insulin sensitivity, reducing glucose production in the liver, and increasing glucose excretion through the kidneys.

Understanding the classification, mechanism of action, therapeutic uses, and adverse effects of antidiabetic drugs is important for pharmacy students preparing for D.Pharm, B.Pharm, GPAT, Drug Inspector, and pharmacist recruitment examinations.

In this article, you will find 30 important MCQs on antidiabetic drugs with answers and explanations to help you revise essential pharmacology concepts and prepare for competitive examinations.

Classification of Antidiabetic Drugs

📝30 Important MCQs on Antidiabetic Drugs

Q1. Which of the following is a biguanide antidiabetic drug?

A) Glimepiride
B) Metformin
C) Pioglitazone
D) Acarbose

Correct Answer: B) Metformin

Explanation: Metformin belongs to the biguanide class and is widely used to treat type 2 diabetes mellitus. It primarily reduces hepatic glucose production and improves insulin sensitivity. When used alone, it generally does not cause hypoglycemia.

Q2. What is the primary mechanism of action of metformin?

A) Stimulation of insulin secretion
B) Inhibition of glucose absorption from the kidneys
C) Reduction of hepatic glucose production
D) Destruction of pancreatic beta cells

Correct Answer: C) Reduction of hepatic glucose production

Explanation: Metformin primarily decreases glucose production in the liver. It also improves insulin sensitivity and glucose utilization in peripheral tissues. Unlike sulfonylureas, it does not directly stimulate insulin secretion.

Q3. Which class of antidiabetic drugs stimulates insulin secretion from pancreatic beta cells?

A) Biguanides
B) Sulfonylureas
C) SGLT2 inhibitors
D) Alpha-glucosidase inhibitors

Correct Answer: B) Sulfonylureas

Explanation: Sulfonylureas stimulate insulin secretion by binding to sulfonylurea receptors on pancreatic beta cells. This closes ATP-sensitive potassium channels, leading to membrane depolarization and insulin release. Examples include glimepiride and glibenclamide.

Q4. Which of the following is a sulfonylurea?

A) Sitagliptin
B) Dapagliflozin
C) Glimepiride
D) Metformin

Correct Answer: C) Glimepiride

Explanation: Glimepiride is a second-generation sulfonylurea used to treat type 2 diabetes mellitus. It increases insulin secretion from pancreatic beta cells. Important adverse effects include hypoglycemia and weight gain.

Q5. Which class of antidiabetic drugs inhibits sodium-glucose cotransporter 2 (SGLT2)?

A) DPP-4 inhibitors
B) SGLT2 inhibitors
C) Sulfonylureas
D) Biguanides

Correct Answer: B) SGLT2 inhibitors

Explanation: SGLT2 inhibitors reduce glucose reabsorption in the kidneys, increasing glucose excretion through urine. Examples include empagliflozin and dapagliflozin. Some drugs in this class also provide cardiovascular and kidney benefits in appropriate patients.

Q6. Which of the following is an SGLT2 inhibitor?

A) Sitagliptin
B) Pioglitazone
C) Dapagliflozin
D) Glibenclamide

Correct Answer: C) Dapagliflozin

Explanation: Dapagliflozin inhibits SGLT2 in the proximal renal tubules, reducing glucose reabsorption. Potential adverse effects include genital fungal infections, dehydration, and, rarely, diabetic ketoacidosis.

Q7. Which class of antidiabetic drugs improves insulin sensitivity by activating PPAR-gamma receptors?

A) Thiazolidinediones
B) Sulfonylureas
C) Meglitinides
D) DPP-4 inhibitors

Correct Answer: A) Thiazolidinediones

Explanation: Thiazolidinediones activate peroxisome proliferator-activated receptor gamma (PPAR-gamma), influencing gene expression involved in glucose and lipid metabolism. This improves insulin sensitivity. Pioglitazone is an example. It may cause fluid retention and weight gain and can worsen heart failure.

Q8. Which of the following is a thiazolidinedione?

A) Repaglinide
B) Pioglitazone
C) Acarbose
D) Linagliptin

Correct Answer: B) Pioglitazone

Explanation: Pioglitazone improves insulin sensitivity in peripheral tissues. It is used in selected patients with type 2 diabetes. Because it can cause fluid retention, it is generally avoided in patients with symptomatic heart failure.

Q9. Which enzyme is inhibited by DPP-4 inhibitors?

A) Cyclooxygenase
B) Dipeptidyl peptidase-4
C) Angiotensin-converting enzyme
D) HMG-CoA reductase

Correct Answer: B) Dipeptidyl peptidase-4

Explanation: DPP-4 inhibitors prevent the breakdown of incretin hormones such as GLP-1. This increases glucose-dependent insulin secretion and reduces glucagon secretion. Examples include sitagliptin and linagliptin.

Q10. Which of the following is a DPP-4 inhibitor?

A) Sitagliptin
B) Metformin
C) Repaglinide
D) Acarbose

Correct Answer: A) Sitagliptin

Explanation: Sitagliptin inhibits the DPP-4 enzyme, prolonging the activity of incretin hormones. It helps control blood glucose and generally has a low risk of hypoglycemia when used alone.

Q11. Which class of antidiabetic drugs delays carbohydrate digestion and absorption in the intestine?

A) Alpha-glucosidase inhibitors
B) Sulfonylureas
C) Biguanides
D) SGLT2 inhibitors

Correct Answer: A) Alpha-glucosidase inhibitors

Explanation: Alpha-glucosidase inhibitors delay the breakdown of complex carbohydrates into absorbable sugars in the small intestine. This reduces post-meal blood glucose elevations. Acarbose is an example. Common adverse effects include flatulence, abdominal discomfort, and diarrhea.

Q12. Which of the following is an alpha-glucosidase inhibitor?

A) Glimepiride
B) Acarbose
C) Empagliflozin
D) Pioglitazone

Correct Answer: B) Acarbose

Explanation: Acarbose inhibits intestinal alpha-glucosidase enzymes, slowing carbohydrate digestion and glucose absorption. It is generally taken with the first bite of a meal when prescribed.

Q13. Which class of antidiabetic drugs is associated with an increased risk of hypoglycemia because it stimulates insulin secretion?

A) Sulfonylureas
B) SGLT2 inhibitors
C) Biguanides
D) Alpha-glucosidase inhibitors

Correct Answer: A) Sulfonylureas

Explanation: Sulfonylureas increase insulin secretion from pancreatic beta cells. This can cause hypoglycemia, particularly when meals are missed or other risk factors are present. Examples include glimepiride and glibenclamide.

Q14. Which of the following is a rapid-acting insulin analogue?

A) Insulin glargine
B) Insulin degludec
C) Insulin lispro
D) NPH insulin

Correct Answer: C) Insulin lispro

Explanation: Insulin lispro is a rapid-acting insulin analogue used to control blood glucose around mealtimes. Insulin glargine and insulin degludec are long-acting insulin analogues, while NPH insulin is intermediate-acting.

Q15. Which insulin preparation is classified as long-acting?

A) Insulin lispro
B) Regular insulin
C) Insulin glargine
D) Insulin aspart

Correct Answer: C) Insulin glargine

Explanation: Insulin glargine provides prolonged basal insulin activity and helps control blood glucose between meals and overnight. It is administered subcutaneously according to the prescribed treatment regimen.

Q16. Which of the following is a GLP-1 receptor agonist?

A) Semaglutide
B) Glibenclamide
C) Metformin
D) Dapagliflozin

Correct Answer: A) Semaglutide

Explanation: Semaglutide activates GLP-1 receptors, increasing glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying. It can also reduce appetite and body weight. Depending on the formulation, it is administered orally or by injection.

Q17. Which adverse effect is commonly associated with GLP-1 receptor agonists?

A) Nausea and vomiting
B) Permanent hearing loss
C) Increased insulin resistance
D) Severe hypoglycemia in every patient

Correct Answer: A) Nausea and vomiting

Explanation: GLP-1 receptor agonists commonly cause gastrointestinal adverse effects, including nausea, vomiting, diarrhea, and constipation. The suitability of these medicines depends on the patient’s clinical history and other risk factors.

Q18. Which of the following is a meglitinide?

A) Repaglinide
B) Sitagliptin
C) Pioglitazone
D) Empagliflozin

Correct Answer: A) Repaglinide

Explanation: Repaglinide is a short-acting insulin secretagogue used to control post-meal blood glucose in type 2 diabetes. It stimulates insulin release from pancreatic beta cells. Hypoglycemia is a potential adverse effect.

Q19. Which antidiabetic drug class increases insulin secretion in a glucose-dependent manner by enhancing incretin activity?

A) DPP-4 inhibitors
B) Sulfonylureas
C) Biguanides
D) Thiazolidinediones

Correct Answer: A) DPP-4 inhibitors

Explanation: DPP-4 inhibitors increase the activity of endogenous incretin hormones by preventing their enzymatic breakdown. This enhances insulin secretion when glucose levels are elevated and helps reduce glucagon secretion.

Q20. Which of the following is a common adverse effect of metformin?

A) Gastrointestinal disturbances
B) Severe hypoglycemia in every patient
C) Fluid retention in all patients
D) Severe weight gain in most patients

Correct Answer: A) Gastrointestinal disturbances

Explanation: Metformin commonly causes nausea, diarrhea, abdominal discomfort, and other gastrointestinal symptoms, particularly when treatment begins. Taking it with food and gradually increasing the dose may improve tolerability. Long-term use can also contribute to vitamin B12 deficiency.

Q21. Which antidiabetic drug class is associated with an increased risk of genital fungal infections?

A) SGLT2 inhibitors
B) Sulfonylureas
C) Biguanides
D) Thiazolidinediones

Correct Answer: A) SGLT2 inhibitors

Explanation: SGLT2 inhibitors increase glucose excretion in urine, which can encourage genital fungal infections. These medicines may also contribute to dehydration and, rarely, diabetic ketoacidosis.

Q22. Which of the following is essential for treating type 1 diabetes mellitus?

A) Insulin
B) Acarbose alone
C) Pioglitazone alone
D) Sitagliptin alone

Correct Answer: A) Insulin

Explanation: Type 1 diabetes involves autoimmune destruction of pancreatic beta cells, resulting in severe insulin deficiency. Insulin replacement is essential for survival. Oral antidiabetic drugs cannot replace the insulin required to manage type 1 diabetes.

Q23. Which antidiabetic drug class is associated with fluid retention and worsening of heart failure?

A) Thiazolidinediones
B) DPP-4 inhibitors
C) Alpha-glucosidase inhibitors
D) Biguanides

Correct Answer: A) Thiazolidinediones

Explanation: Thiazolidinediones, such as pioglitazone, can cause sodium and fluid retention. This may worsen heart failure in susceptible patients. These medicines should be avoided in patients with symptomatic heart failure.

Q24. Which antidiabetic drug primarily reduces post-meal glucose absorption by acting in the intestine?

A) Acarbose
B) Insulin glargine
C) Pioglitazone
D) Sitagliptin

Correct Answer: A) Acarbose

Explanation: Acarbose inhibits intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and glucose absorption. This helps reduce postprandial blood glucose elevations.

Q25. Which of the following is a second-generation sulfonylurea?

A) Glibenclamide
B) Metformin
C) Dapagliflozin
D) Semaglutide

Correct Answer: A) Glibenclamide

Explanation: Glibenclamide, also known as glyburide, is a second-generation sulfonylurea. It stimulates insulin secretion from pancreatic beta cells. Hypoglycemia can be prolonged, particularly in older adults and people with impaired kidney function.

Q26. Which antidiabetic drug primarily reduces hepatic glucose production?

A) Metformin
B) Glimepiride
C) Repaglinide
D) Insulin lispro

Correct Answer: A) Metformin

Explanation: Metformin reduces hepatic glucose production and improves insulin sensitivity. It is widely used in type 2 diabetes, although its use and dosing depend on kidney function and other clinical considerations.

Q27. Which drug class activates GLP-1 receptors and can promote weight loss?

A) GLP-1 receptor agonists
B) Sulfonylureas
C) Biguanides
D) Alpha-glucosidase inhibitors

Correct Answer: A) GLP-1 receptor agonists

Explanation: GLP-1 receptor agonists mimic the action of the naturally occurring incretin hormone GLP-1. They improve glucose-dependent insulin secretion, suppress glucagon when appropriate, and often promote weight loss.

Q28. Which of the following is a common risk associated with insulin therapy?

A) Hypoglycemia
B) Reduced glucose uptake
C) Permanent inhibition of insulin secretion
D) Increased blood glucose in every patient

Correct Answer: A) Hypoglycemia

Explanation: Insulin lowers blood glucose by promoting glucose uptake and reducing hepatic glucose production. Excess insulin relative to food intake, physical activity, or physiological needs can cause hypoglycemia. Patients using insulin need appropriate dose management, glucose monitoring, and education about recognizing and treating low blood glucose.

Q29. Which statement about metformin in type 2 diabetes is correct?

A) It always causes severe hypoglycemia when used alone.
B) It primarily stimulates insulin release from pancreatic beta cells.
C) It reduces hepatic glucose production and is a common treatment option.
D) It is the only medicine used to treat type 2 diabetes.

Correct Answer: C) It reduces hepatic glucose production and is a common treatment option.

Explanation: Metformin reduces hepatic glucose production and improves insulin sensitivity. It is commonly used in type 2 diabetes, but treatment should be individualized. Depending on cardiovascular disease, kidney disease, heart failure, weight goals, and other factors, another medicine may be preferred or added.

Q30. What is the primary goal of antidiabetic drug therapy?

A) To increase blood glucose above normal
B) To maintain appropriate blood glucose levels and reduce complications
C) To stop all carbohydrate absorption
D) To eliminate the need for monitoring in every patient

Correct Answer: B) To maintain appropriate blood glucose levels and reduce complications

Explanation: Antidiabetic treatment aims to achieve individualized blood glucose targets, reduce symptoms, and prevent or delay diabetes-related complications. Treatment plans may include medication, appropriate nutrition, physical activity, glucose monitoring, and regular medical follow-up.

📑Quick Revision Table: Important Antidiabetic Drugs

📋Frequently Asked Questions (FAQs)

1. Which antidiabetic drug is commonly used as an initial treatment for type 2 diabetes?

Metformin is a common initial treatment option for type 2 diabetes. However, treatment choice depends on individual needs, kidney function, cardiovascular disease, kidney disease, and other clinical factors.

2. Which antidiabetic drugs can cause hypoglycemia?

Insulin, sulfonylureas, and meglitinides are particularly associated with hypoglycemia. The risk depends on the dose, food intake, physical activity, kidney function, and other medicines.

3. Which antidiabetic drugs can promote weight loss?

GLP-1 receptor agonists, such as semaglutide, and some SGLT2 inhibitors can promote weight loss. The amount varies by medicine and individual patient.

4. What is the difference between type 1 and type 2 diabetes treatment?

Type 1 diabetes requires insulin replacement. Type 2 diabetes may be managed with lifestyle measures, oral medicines, injectable medicines, insulin, or combinations, depending on the patient’s condition.

5. Are these MCQs useful for D.Pharm and B.Pharm examinations?

Yes. These questions cover important pharmacology concepts relevant to D.Pharm, B.Pharm, GPAT, and pharmacist recruitment examinations. The exact syllabus and examination pattern may vary.

🎯 Conclusion

These 30 MCQs on antidiabetic drugs cover important topics, including drug classification, mechanisms of action, therapeutic uses, and adverse effects. Practising these questions can help D.Pharm and B.Pharm students strengthen their pharmacology knowledge and prepare for competitive examinations.

For better preparation, revise each drug class alongside its mechanism of action, important examples, and adverse effects.

Disclaimer: This article is intended for educational purposes and should not replace professional medical advice. Antidiabetic medicines should be used under the guidance of a qualified healthcare professional.